PC

Pentwater Capital Management

North America, Florida, United States, Naples

Description

Pentwater Capital Management Is an investment firm

Investor Profile

Pentwater Capital Management has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, Denmark.
  • Strong thematic focus on Biotechnology, Biopharma, Genetics.

Stage Focus

  • Series C (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (50%)
  • Denmark (50%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Genetics
  • Therapeutics
  • Collaboration
  • Pet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pentwater Capital Management frequently co-invest with?

Rapha Capital Management
North America, New York, United States, Florida
Co-Investments: 1
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Malin Corporation
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 1

What are some of recent deals done by Pentwater Capital Management?

Curasight A/S

Copenhagen, Hovedstaden, Denmark

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications.

BiotechnologyCollaborationPet
Post Ipo EquityMay 21, 2025
Amount Raised: $7,139,030
Poseida Therapeutics

San Diego, California, United States

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

BiopharmaBiotechnologyGeneticsTherapeutics
Series CApr 22, 2019
Amount Raised: $142,000,000

Find More Investors Like Pentwater Capital Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Pentwater Capital Management | Pipeseed